Mycophenolic Acid (MPA) Dosing: Effect on Efficacy to 4 Years after Kidney Transplantation in the Mycophenolic Acid Observational Renal Transplant (MORE) Study.

被引：0
|
作者：
Chan, L. [1 ]
Shihab, F. [2 ]
Pankewycz, O. [3 ]
Doria, C. [4 ]
Wiland, A. [5 ]
McCague, K. [5 ]
Langone, A. [6 ]
机构：
[1] Univ Colorado, Sch Med, Aurora, CO USA
[2] Univ Utah, Sch Med, Salt Lake City, UT USA
[3] Erie Cty Med Ctr & Labs, Buffalo, NY USA
[4] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[5] Novartis Pharmaceut, E Hanover, NJ USA
[6] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [21] Corticosteroid Withdrawal in Renal Transplant Recipients: An Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry.
    Ueda, K.
    Wiland, A.
    Mccague, K.
    Peddi, V. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 442 - 442
  • [22] Determinants of mycophenolic acid levels after renal transplantation
    Borrows, R
    Chusney, G
    James, A
    Stichbury, J
    Van Tromp, J
    Cairns, T
    Griffith, M
    Hakim, N
    McLean, A
    Palmer, A
    Papalois, V
    Taube, D
    THERAPEUTIC DRUG MONITORING, 2005, 27 (04) : 442 - 450
  • [23] Effect of cyclosporine (CyA) on mycophenolic acid (MPA) pharmacokinetics (PK) in a pediatric kidney transplant population. Results of a prospective longitudinal study.
    Belingheri, M
    Ferraresso, M
    Ghio, L
    Ginevri, F
    Perfumo, F
    Peruzzi, L
    Murer, L
    Zacchello, G
    Cardillo, M
    Tirelli, S
    Edefonti, A
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 53 - 53
  • [24] Pharmacokinetic study of mycophenolic acid in pediatric kidney transplantation
    Fuentes, Pia Boza
    Osorio, Dominique Yanez
    Giacomozzi, Natalie Espinoza
    Morales, Alonso de la Rivera
    Lozano, Angelica Rojo
    Bicocchi, Angela Delucchi
    Palma, Carolina Salas
    ANDES PEDIATRICA, 2022, 93 (02): : 184 - 191
  • [25] Efficacy and Safety of Cessation and/or Reduction of Mycophenolic Acid (MPA) in BK Viremia Post-Renal Transplant
    Chakraborty, Ramyangshu
    Allan, Michelle E.
    Kashem, Tasnuva S.
    Mccafferty, Kieran
    Fan, Stanley
    Moguel, Teresa M. Cutino
    Yaqoob, Muhammad Magdi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 976 - 976
  • [26] Mycophenolic acid monitoring:: Evaluation of the EMIT MPA immunoassay in kidney and lung transplantation
    Brunet, M
    Oppenheimer, F
    Martorell, J
    Vilardell, J
    Carreño, MC
    Carrillo, M
    Corbella, J
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (06) : 2275 - 2276
  • [27] Pharmacokinetics of mycophenolic acid in the early period after kidney transplantation
    Wollenberg, K
    Krumme, B
    Pisarski, P
    Schollmeyer, P
    Kirste, G
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) : 4090 - 4091
  • [28] Effect of mycophenolic acid and tacrolimus on the incidence of infectious complications after kidney transplantation
    Matej, Vnucak
    Karol, Granak
    Petra, Skalova
    Ludovit, Laca
    Marian, Mokan
    Ivana, Dedinska
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 98
  • [29] Effect of Mycophenolic Acid and Tacrolimus on the Incidence of Infectious Complications After Kidney Transplantation
    Vnucak, Matej
    Granak, Karol
    Beliancinova, Monika
    Dedinska, Ivana
    TRANSPLANTATION, 2022, 106 (09) : S123 - S124
  • [30] The variability in pharmacokinetic profiles of mycophenolic acid after renal transplantation
    Zdrojewski, Z
    Wolyniec, W
    Debska-Slizien, A
    Chamienia, A
    Rutkowski, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 362A - 362A
12345